- Filed
- Nov 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 31, 2025 | 50.07M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 50.13M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 50.11M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 49.42M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 49.26M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $8M |
| Capex | Q3 2025 · Sep 30, 2025 | $10.97M |
| Capex | Q3 2025 · Sep 30, 2024 | $12.04M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$9.5M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$10.84M |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $165.5M |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $216.46M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $255.81M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $34.14M |
| Cash And Equivalents restated | Q3 2025 · Sep 30, 2024 | $31.37M |
| Cash And Equivalents restated | Q3 2025 · Dec 31, 2023 | $35.19M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $513.27M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $519.08M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $401.9M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $418.57M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $400.1M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $489.02M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $30.75M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $64.56M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $261.06M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $301.6M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $484.84M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $341.57M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $774.33M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $703.49M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.18 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $1.68 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.02 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$2.07 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.18 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $1.68 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.02 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$2.07 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $26.73M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $75.54M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $26.67M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $81.73M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $4.52M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $12.58M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $4.16M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $13.56M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$6.94M |
| Net Income | Q3 2025 · Sep 30, 2025 | $89.95M |
| Net Income | Q3 2025 · Sep 30, 2024 | $805K |
| Net Income | Q3 2025 · Sep 30, 2024 | −$96.08M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$9.93M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$26.78M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$13.39M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$108.93M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $21.33M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $61.34M |
| Gross Profit restated | Q3 2025 · Sep 30, 2024 | $17.44M |
| Gross Profit restated | Q3 2025 · Sep 30, 2024 | $50.16M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $22.91M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $69.38M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $20.88M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $65.15M |
| Revenue | Q3 2025 · Sep 30, 2025 | $44.23M |
| Revenue | Q3 2025 · Sep 30, 2025 | $130.73M |
| Revenue | Q3 2025 · Sep 30, 2024 | $38.32M |
| Revenue | Q3 2025 · Sep 30, 2024 | $115.32M |